BVS vs PAYC · rev $573.3M vs P/E 33, rev $1.88B
Bioventus Inc (BVS) versus Paycom Soft (PAYC) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
Paycom Soft (PAYC) is a software - application company listed on US.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
Latest reported PAYC revenue for 2024-12-31 was $1.88B. Net income was $502.0M. Revenue was up 11.2% from 2023-12-31 to 2024-12-31. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
BVS currently screens at market cap $495.1M. PAYC currently screens at market cap $13.06B and trailing P/E 33.1.
Not investment advice. Open the BVS and PAYC stock pages for the full models.
Not investment advice.